A quantitative analysis of the costs and benefits of prostate cancer screening

Prostate Cancer and Prostatic Diseases

Volumn 4, Issue 3, 2001, Pages 138-145

  Benoit, R M ^a   Gronberg H ^b   Naslund, M J ^c  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b UMEÅ UNIVERSITY   (Sweden)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cost; Cost effectiveness; Prostate cancer screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DATA BASE; ECONOMIC ASPECT; HEALTH CARE COST; HUMAN; INTESTINE EXAMINATION; MAJOR CLINICAL STUDY; MALE; MEDICARE; MODEL; MORBIDITY; POPULATION RESEARCH; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; RECTUM; RELIABILITY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0034808228     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500510     Document Type: Article

References (36)

1. A decision analysis of alternative treatment strategies for clinically localized prostate cancer
2. Screening for prostate cancer: A decision analytic view
3. Cancer statistics, 2000
4. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination
5. Detection of organ confined prostate cancer is increased through prostate-specific antigen-based screening
6. The palpable nodule of prostatic cancer: Results 15y after radical excision
7. Course of localized adenocarcinoma of the prostate treated by radical prostatectomy
8. Radical retropubic prostatectomy for cancer: A 20-year experience
9. Patient age as a prognostic factor in prostate cancer
10. Complications of radical retropubic prostatectomy
11. Perioperative and postoperative complications for bilateral pelvic lymphadenectomy and radical retropubic prostatectomy
12. Mortality of patients after radical prostatectomy: Analysis of recent medicare claims
13. An economic rationale for prostate cancer screening
14. Many factors influence hospital charges for radical retropubic prostatectomy
15. Economics of screening for carcinoma of the prostate
16. Impact of anatomical radical prostatectomy on urinary incontinence
17. Radical retropublic prostatectomy: Morbidity and quality of life experience with 620 cases
18. Total prostatectomy for clinically localized prostate cancer: Long-term surgical results and current morbidity
19. Patient-reported complications and follow-up after radical prostatectomy
20. Collagen implantation for post-prostatectomy incontinence: Early experience with a transrectal ultrasonographically guided method
21. Anastomotic strictures following radical prostatectomy: Risk factors and management
22. Impact of routine screening for adenocarcinoma of the prostate on stage distribution
23. Adenocarcinoma of the prostate: Results of routine urological screening
24. Questioning the value of screening for prostate cancer in asymptomatic men
25. Screening for prostatic carcinoma
26. Prostate cancer screening: Current trends and future implications
27. The benefit and cost of prostate cancer early detection. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project
28. Screening for prostate cancer
29. Screening for prostatic carcinoma with prostate specific antigen: Results of the second year
30. Radical retropubic prostatectomy with reduced morbidity: An anatomic approach
31. High 10-year survival rate in patients with early, untreated prostatic cancer
32. Long-term survival among men with conservatively treated localized prostate cancer
33. Detection of latent prostate cancer from routine screening: Comparison with breast cancer screening
34. Clinical stage BO or T1c prostate cancer: Nonpalpable disease identified by elevated serum prostate-specific antigen concentration